Colorectal cancer : disease and advanced drug delivery strategies /
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
London, United Kingdom ; San Diego, CA :
Academic Press, an imprint of Elsevier,
[2024]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- Colorectal Cancer
- Copyright Page
- Dedication
- Contents
- List of contributors
- Preface
- Acknowledgments
- 1 Colorectal cancer: understanding of disease
- 1.1 Introduction
- 1.2 Understanding of disease: colorectal cancer
- 1.2.1 Etiology and pathogenesis
- 1.2.1.1 Environmental factors correlated to the incidence of colorectal cancer
- 1.2.1.1.1 Dietary fat and meat intake
- 1.2.1.1.2 Vegetables, fruits, and fibers
- 1.2.1.1.3 Smoking Cigarette
- 1.2.1.1.4 Alcohol
- 1.2.1.2 Genes involved in the prognosis and pathogenesis of colorectal cancer
- 1.3 Diagnosis for colorectal cancer
- 1.4 Treatment for colorectal cancer
- 1.4.1 Endoscopic treatment
- 1.4.2 Chemotherapy
- 1.4.3 Radiotherapy
- 1.4.4 Targeted therapies
- 1.5 Recent advances in the therapeutic interventions of colorectal cancer
- 1.6 Conclusion
- Abbreviations
- References
- 2 Impact of the microbiome on colorectal cancer development
- 2.1 Introduction
- 2.2 Gut microbiome and colorectal cancer
- 2.2.1 Induction of inflammation by gut microbiota
- 2.2.2 Dysbiosis and gut microbiota (functional diversity of gut microbiota)
- 2.2.3 Bacterial microbiota and colorectal cancer
- 2.2.4 Viral microbiota and colorectal cancer
- 2.2.5 Fungal microbiota and colorectal cancer
- 2.3 Gut microbiota and its derived metabolites
- 2.4 Host microbiota interactions with genomes and epigenomes
- 2.4.1 Interactions with the genome
- 2.4.1.1 Cell cycle regulation
- 2.4.1.2 DNA damage
- 2.4.1.3 Genomic instability
- 2.4.2 Interactions with the epigenome
- 2.4.2.1 DNA methylation
- 2.4.2.2 miRNAs
- 2.4.2.3 Histone modifications
- 2.5 Linking antibiotic-microbiome: risk and attribution of leaky gut to colorectal cancer
- 2.6 Intestinal stem cells and colorectal cancer
- 2.6.1 Intestinal stem cells and their homeostasis
- 2.6.2 Intestinal stem cells or cancer stem cells markers in colorectal cancer
- 2.6.3 Pathways regulating ISCs/CSCs in colorectal cancer
- 2.7 Prognostic or diagnostic microbiome-associated early diagnosis
- 2.8 Therapeutic impact of the gut microbiome on the efficacy of chemotherapy
- 2.9 Preventive dietary mediators and their protective potential in colorectal cancer
- 2.9.1 Dietary fibers
- 2.9.2 Polyunsaturated fatty acids
- 2.9.3 Polyphenols
- 2.9.4 Probiotics